Incorporation of clinical and molecular variant properties improves the performance of in silico pathogenicity prediction tools.

Isakov O, Ashwal-Fluss R, Marek-Yagel D, Sunyaev S, Ben-Shachar S.

Shamil Sunyaev

Genet Med

May 1, 2026

http://www.ncbi.nlm.nih.gov/pubmed/41904679

28(5):102557

https://connects.catalyst.harvard.edu/Profiles/profile/334634118

Incorporation of clinical and molecular variant properties improves the performance of in silico pathogenicity prediction tools.

Isakov O, Ashwal-Fluss R, Marek-Yagel D, Sunyaev S, Ben-Shachar S.

Shamil Sunyaev

Genet Med

May 1, 2026

http://www.ncbi.nlm.nih.gov/pubmed/41904679

28(5):102557

https://connects.catalyst.harvard.edu/Profiles/profile/334634118